Treatment of posttraumatic stress disorder: Focus on pharmacotherapy
Open accessAbstract
Current clinical practice guidelines for the treatment of posttraumatic stress disorder offer varying recommendations regarding the use of pharmacotherapy. Many direct head-to-head comparisons of pharmacotherapy are lacking, and recommendations are based on meta-analyses and small trials. While selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors are considered first-line pharmacotherapy, clear distinctions do not exist when considering other classes of psychotropic medications. Ultimately, when selecting an appropriate medication for a patient diagnosed with posttraumatic stress disorder, the clinician needs to consider the current symptomatology being experienced, comorbid conditions, and evidence for efficacy of specific treatments prior to initiating medications.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Clinicians may consider various factors in selecting an appropriate medication, such as type and severity of symptoms and comorbid conditions experienced by the individual diagnosed with PTSD.
“clinicians may consider various factors in selecting an appropriate medication such as type and severity of symptoms and comorbid conditions experienced by the individual diagnosed with PTSD [23].”
From Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States-a retrospective claims study (2023) · cites this paper as [23]
The Abstract says clinicians should consider current symptoms and comorbid conditions when selecting medication for a patient with PTSD. The Case 1 discussion likewise recommends identifying specific symptoms, but the passages do not identify symptom severity as a medication-selection factor. No page numbers are provided in our copy. (LLM, conf=0.84)
Experimental — accuracy not yet measuredPTSD-specific clinical management may help reduce the overall disease burden and often involves careful assessment of the nature of the trauma and provision of trauma-focused psychotherapy and/or pharmacological treatments.
“PTSD-specific clinical management of patients with PTSD may help to reduce the overall disease burden and often involves careful assessment of the nature of the trauma and provision of trauma-focused psychotherapy and/or pharmacological treatments [9,23,24].”
From Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States-a retrospective claims study (2023) · cites this paper as [23]
The Introduction describes traumatic-event exposure as part of PTSD diagnosis, and the Conclusion recommends trauma-focused psychotherapy first-line, with medication in specified circumstances. The Take Home Points report improvement in PTSD symptoms with treatment. However, the paper does not explicitly describe careful assessment of the nature of the trauma as a routine part of clinical management or establish a reduction in overall disease burden. (LLM, conf=0.78)
Experimental — accuracy not yet measuredThe only medications approved for PTSD in the US are SSRIs (sertraline and paroxetine), while other medications may also be used off label.
“While the only medications approved for PTSD in the US are SSRIs (i.e.sertraline and paroxetine) [25], other medications may also be used off label [23,27]”
From Patient journey before and after a formal post-traumatic stress disorder diagnosis in adults in the United States-a retrospective claims study (2023) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369 · see citing works
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090 · see citing works
Meta-Analysis of the Efficacy of Treatments for Posttraumatic Stress Disorder
Watts, B. V., Schnurr, P. P., Mayo, L., Young-Xu, Y., Weeks, W. B., & Friedman, M. J. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r08225 · Cited by 985 · see citing works
Pietrzak, R. H., Goldstein, R. B., Southwick, S. M., & Grant, B. F. (2011) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2010.11.010 · Cited by 963 · cited 1× · see citing works
“functional difficulties, reduced quality of life, and adverse physical health outcomes.(4)”
BackgroundBaldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676 · see citing works
Goldstein, R. B., Smith, S. M. R., Chou, S. P., Saha, T. D., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Huang, B., & Grant, B. F. (2016) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1208-5 · Cited by 674 · see citing works
Raskind, M. A., Peskind, E. R., Kanter, E. D., Petrie, E. C., Radant, A. D., Thompson, C. E., Dobie, D. J., Hoff, D., Rein, R. J., Straits-Tröster, K. A., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.2.371 · Cited by 607 · see citing works
Raskind, M. A., Peskind, E. R., Hoff, D. J., Hart, K. L., Holmes, H. A., Warren, D., Shofer, J. B., O’Connell, J., Taylor, F., Gross, C., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.032 · Cited by 554 · see citing works
Pharmacotherapy for post-traumatic stress disorder: Systematic review and meta-analysis
Hoskins, M., Pearce, J., Bethell, A., Dankova, L., Barbui, C., Tol, W. A., van Ommeren, M., de Jong, J., Seedat, S., Chen, H., et al. (2015) · British Journal of Psychiatry · doi:10.1192/bjp.bp.114.148551 · Cited by 418 · see citing works
Lee, D. J., Schnitzlein, C. W., Wolf, J. P., Vythilingam, M., Rasmusson, A. M., & Hoge, C. W. (2016) · Depression and Anxiety · doi:10.1002/da.22511 · Cited by 416 · see citing works
Rothbaum, B. O., Price, M., Jovanovic, T., Norrholm, S. D., Gerardi, M., Dunlop, B., Davis, M., Bradley, B., Duncan, E. J., Rizzo, A., et al. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2014.13121625 · Cited by 388 · see citing works
Raskind, M. A., Peterson, K. A., Williams, T., Hoff, D. J., Hart, K. L., Holmes, H. A., Homas, D., Hill, J., Daniels, C., Calohan, J., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12081133 · Cited by 356 · see citing works
Trial of prazosin for post-traumatic stress disorder in military veterans
Raskind, M. A., Peskind, E. R., Chow, B., Harris, C., Davis-Karim, A., Holmes, H. A., Hart, K. L., McFall, M., Mellman, T. A., Reist, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1507598 · Cited by 342 · see citing works
Taylor, F. B., Martin, P., Thompson, C., Williams, J., Mellman, T. A., Gross, C., Peskind, E. R., & Raskind, M. A. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.07.001 · Cited by 336 · see citing works
A guide to guidelines for the treatment of PTSD and related conditions
Forbes, D., Creamer, M., Bisson, J. I., Cohen, J. A., Crow, B. E., Foa, E. B., Friedman, M. J., Keane, T. M., Kudler, H. S., & Ursano, R. J. (2010) · Journal of Traumatic Stress · doi:10.1002/jts.20565 · Cited by 307 · see citing works
Rummel‐Kluge, C., Komossa, K., Schwarz, S., Hunger, H., Schmid, F., Kissling, W., Davis, J. M., & Leucht, S. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq042 · Cited by 272 · see citing works
Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder (PTSD) in Adults
(2017) · PsycEXTRA Dataset · doi:10.1037/e501872017-001 · Cited by 266 · see citing works
VA/DoD Clinical Practice Guideline for the Management of Post-Traumatic Stress
(2004) · PsycEXTRA Dataset · doi:10.1037/e610262007-001 · Cited by 239 · see citing works
Pharmacotherapy for Posttraumatic Stress Disorder Using Phenelzine or Imipramine
Kosten, T. R., FRANK, J. B., Dan, E., McDougle, C. J., & Giller, E. L. (1991) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199106000-00011 · Cited by 238 · see citing works
Antipsychotic‐Induced Hyperprolactinemia
Bostwick, J. R., Guthrie, S. K., & Ellingrod, V. L. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.1.64 · Cited by 237 · see citing works
Germain, A., Richardson, R., Moul, D. E., Mammen, O. K., Haas, G. L., Forman, S. D., Rode, N., Begley, A. E., & Nofzinger, E. A. (2011) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2011.11.010 · Cited by 231 · see citing works
Morgenthaler, T. I., Auerbach, S., Casey, K. R., Kristo, D., Maganti, R., Ramar, K., Zak, R., & Kartje, R. (2018) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7178 · Cited by 230 · see citing works
(1990) · PubMed · Cited by 222 · see citing works
Krystal, J. H., Rosenheck, R. A., Cramer, J. A., Vessicchio, J. C., Jones, K. M., Vertrees, J. E., Horney, R. A., Huang, G. D., Stock, C. J., & for the Veterans Affairs Cooperative Study No. 504 Group (2011) · JAMA · doi:10.1001/jama.2011.1080 · Cited by 220 · see citing works
Ramchand, R., Rudavsky, R., Grant, S., Tanielian, T., & Jaycox, L. H. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0575-z · Cited by 212 · see citing works
Smith, S. M. R., Goldstein, R. B., & Grant, B. F. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.06.022 · Cited by 178 · see citing works
Nutt, D. J., & Stahl, S. M. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109106927 · Cited by 163 · see citing works
Taylor, F., & Raskind, M. A. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00013 · Cited by 161 · see citing works
Raskind, M. A., Dobie, D. J., Kanter, E. D., Petrie, E. C., Thompson, C. E., & Peskind, E. R. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0208 · Cited by 154 · see citing works
Cipriani, A., Williams, T., Nikolakopoulou, A., Salanti, G., Chaimani, A., Ipser, J., Cowen, P. J., Geddes, J. R., & Stein, D. J. (2017) · Psychological Medicine · doi:10.1017/s003329171700349x · Cited by 150 · see citing works
Treating nightmares and insomnia in posttraumatic stress disorder: A review of current evidence
Nappi, C. M., Drummond, S. P. A., & Hall, J. M. H. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.02.029 · Cited by 141 · see citing works
Prazosin Reduces Trauma-Related Nightmares in Older Men with Chronic Posttraumatic Stress Disorder
Peskind, E. R., Bonner, L. T., Hoff, D. J., & Raskind, M. A. (2003) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988703256050 · Cited by 127 · see citing works
Villarreal, G., Hamner, M. B., Cañive, J. M., Robert, S., Calais, L. A., Durklaski, V., Zhai, Y., & Qualls, C. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15070967 · Cited by 112 · see citing works
Cates, M. E., Bishop, M. H., Davis, L. L., Lowe, J. S., & Woolley, T. W. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1e043 · Cited by 105 · see citing works
Divalproex in the Treatment of Posttraumatic Stress Disorder
Davis, L. L., Davidson, J. R. T., Ward, L. C., Bartolucci, A., Bowden, C. L., & Petty, F. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318160f83b · Cited by 102 · see citing works
Eszopiclone for the Treatment of Posttraumatic Stress Disorder and Associated Insomnia
Pollack, M. H., Hoge, E. A., Worthington, J. J., Moshier, S. J., Wechsler, R. S., Brandes, M., & Simon, N. M. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.09m05607gry · Cited by 101 · see citing works
Risk Factors, Methods, and Timing of Suicide Attempts Among US Army Soldiers
Ursano, R. J., Kessler, R. C., Stein, M. B., Naifeh, J. A., Aliaga, P. A., Fullerton, C. S., Wynn, G. H., Vegella, P. L., Ng, T. H. H., Zhang, B. G., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0600 · Cited by 92 · see citing works
Disinhibitory reactions to benzodiazepines: A review
van der Bijl, P., & Roelofse, J. (1991) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/0278-2391(91)90180-t · Cited by 87 · see citing works
Ahmadpanah, M., Sabzeiee, P., Hosseini, S. M., Torabian, S., Haghighi, M., Jahangard, L., Bajoghli, H., Holsboer‐Trachsler, E., & Brand, S. (2014) · Neuropsychobiology · doi:10.1159/000362243 · Cited by 80 · see citing works
Forman-Hoffman, V., Middleton, J., Feltner, C., Gaynes, B., Weber, R., Bann, C., Viswanathan, M., Lohr, K., Baker, C. E., & Green, J. (2018) · doi:10.23970/ahrqepccer207 · Cited by 78 · see citing works
Matar, M. A., Zohar, J., Kaplan, Z., & Cohen, H. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.12.004 · Cited by 74 · see citing works
A Placebo-Controlled Study of Nefazodone for the Treatment of Chronic Posttraumatic Stress Disorder
Davis, L. L., Jewell, M. E., Ambrose, S. M., Farley, J. E., English, B. A., Bartolucci, A., & Petty, F. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000125685.82219.1a · Cited by 73 · see citing works
Declining Benzodiazepine Use in Veterans With Posttraumatic Stress Disorder
Lund, B. C., Alexander, B., Bernardy, N. C., & Friedman, M. J. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06775 · Cited by 71 · see citing works
Olanzapine in the treatment‐resistant, combat‐related PTSD – a series of case reports
Jakovljević, M., Šagud, M., & Mihaljević-Peleš, A. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2003.00065.x · Cited by 69 · see citing works
COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL
Schneier, F. R., Campeas, R. B., Carcamo, J., Glass, A., Lewis‐Fernández, R., Neria, Y., Sánchez-Lacay, A., Vermes, D., & Wall, M. M. (2015) · Depression and Anxiety · doi:10.1002/da.22384 · Cited by 61 · see citing works
Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder
McRae‐Clark, A. L., Brady, K. T., Mellman, T. A., Sonne, S. C., Killeen, T. K., Timmerman, M. A., & Bayles-Dazet, W. (2004) · Depression and Anxiety · doi:10.1002/da.20008 · Cited by 60 · see citing works
Clinical pharmacology and therapeutics of benzodiazepines.
Sellers, E. M. (1978) · PubMed Central · Cited by 53 · see citing works
Pharmacology for sleep disturbance in PTSD
Lipinska, G., Baldwin, D. S., & Thomas, K. G. F. (2016) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2522 · Cited by 53 · see citing works
Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD
David, D., Faria, L. D., & Mellman, T. A. (2006) · Depression and Anxiety · doi:10.1002/da.20187 · Cited by 51 · see citing works
Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans
Harpaz-Rotem, I., Rosenheck, R. A., Mohamed, S., & Desai, R. A. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.10.1184 · Cited by 51 · see citing works
Lambert, M. T. (2006) · International Clinical Psychopharmacology · doi:10.1097/01.yic.0000185021.48279.00 · Cited by 50 · see citing works
Boynton, L. D., Bentley, J. A., Strachan, E. D., Barbato, A., & Raskind, M. A. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000364287.63210.92 · Cited by 49 · see citing works
Daly, C. M., Doyle, M. E., Radkind, M., Raskind, E., & Daniels, C. (2005) · Military Medicine · doi:10.7205/milmed.170.6.513 · Cited by 49 · see citing works
Stanovic, J. K., James, K. A., & VanDevere, C. A. (2001) · Journal of Burn Care & Rehabilitation · doi:10.1097/00004630-200105000-00005 · Cited by 38 · see citing works
The natural history of tolerance to the benzodiazepines
Higgitt, A., Fonagy, P., & Lader, M. (1988) · Psychological Medicine. Monograph Supplement · doi:10.1017/s0264180100000412 · Cited by 37 · see citing works
Diazepam enhances conditioned defeat in hamsters (Mesocricetus auratus)
Hebert, M. A., Potegal, M., Moore, T. O., Evenson, A. R., & Meyerhoff, J. L. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00110-4 · Cited by 24 · see citing works
Should We be Worried About QTc Prolongation Using Citalopram? A Review
Hutton, L. M. J., Cave, A., Jean, R. S., & Banh, H. L. (2016) · Journal of Pharmacy Practice · doi:10.1177/0897190015624862 · Cited by 19 · see citing works
Nefazodone versus sertraline in the treatment of posttraumatic stress disorder
Saygın, M. Z., Sungur, M. Z., Sabol, E. U., & Çetinkaya, P. D. (2002) · Psychiatry and Clinical Psychopharmacology · Cited by 18 · see citing works
Flagged first, then by citations
Research works printed but not linked: 2
- [13]National Institute for Health and Care Excellence Post-traumatic stress disorder (NICE Quality Standard NG116) [Internet] c 2018 [cited 2019 Sep 9]. Available from: https://www.nice.org.uk.guidance/ng116/evidenc 31211536
- [34]Kilpatrick D Resnick H Freedy J Pelcovitz D Resick R Roth S Posttraumatic stress disorder field trial: evaluation of PTSD construct criteria A through E Widiger T Frances A Pincus H DSM-IV Sourcebook Washington American Psychiatric Press 1994
Cited by
Sorted by citations
Tanaka, M., Szabó, Á., Spekker, E., Polyák, H., Tóth, F., & Vécsei, L. (2022) · Cells · doi:10.3390/cells11162607 · Cited by 160 · see citing works
Nickson, D., Meyer, C., Walasek, L., & Toro, C. T. (2023) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-023-02341-x · Cited by 81 · see citing works
A review for the pharmacological effects of paeoniflorin in the nervous system
Hong, H., Lu, X., Wu, C., Chen, J., Chen, C., Zhang, J., Huang, C., & Cui, Z. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.898955 · Cited by 76 · see citing works
Constable, P. A., Al-Dasooqi, D., Bruce, R., & Senthil, M. P. (2022) · Clinical Optometry · doi:10.2147/opto.s355091 · Cited by 48 · see citing works
Neurobiological Trajectories Involving Social Isolation in PTSD: A Systematic Review
Vlachos, I. I., Papageorgiou, C., & Margariti, M. M. (2020) · Brain Sciences · doi:10.3390/brainsci10030173 · Cited by 40 · see citing works
Sottile, R., & Vida, T. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.991753 · Cited by 35 · see citing works
Davis, L. L., & Hamner, M. B. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1356563 · Cited by 32 · see citing works
A multispecies probiotic accelerates fear extinction and inhibits relapse in mice: Role of microglia
Cui, X., Zhou, S., Xia, G., Chen, J., Jiang, L., Huang, J., & Tong, J. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108613 · Cited by 26 · see citing works
Glavonic, E., Mitić, M., & Adžić, M. (2022) · Journal of Neuroscience Research · doi:10.1002/jnr.25017 · Cited by 21 · see citing works
Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
Makunts, T., Jerome, L., Abagyan, R. A., & de Boer, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.824288 · Cited by 20 · see citing works
Quetiapine Treatment for Post-traumatic Stress Disorder: A Systematic Review of the Literature
Crapanzano, C., Damiani, S., Casolaro, I., & Amendola, C. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2023.21.1.49 · Cited by 19 · see citing works
Moore, B. A., Pujol, L. A. M., Waltman, S. H., & Shearer, D. S. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-020-01220-w · Cited by 17 · see citing works
Lefaucheur, J. P., Valeyrie‐Allanore, L., Tin, S. N. W., Abgrall, G., Colin, A., Hajj, C., de Prost, N., Wolkenstein, P., Oro, S., & Chosidow, O. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16891 · Cited by 17 · see citing works
Novel Pharmacological Targets of Post-Traumatic Stress Disorders
Marazziti, D., Carmassi, C., Cappellato, G., Chiarantini, I., Massoni, L., Mucci, F., Arone, A., Violi, M., Palermo, S., Iorio, G. D., et al. (2023) · Life · doi:10.3390/life13081731 · Cited by 18 · see citing works
Post-Traumatic Stress Disorder (PTSD) in Trauma Patients
Radow, B. S., Anderson, N., & Richmond, B. K. (2024) · The American Surgeon · doi:10.1177/00031348241290610 · Cited by 12 · see citing works
Kong, C. H., Min, H. S., Jeon, M., Kang, W. C., Park, K., Kim, M. S., Jung, S. Y., Bae, H. J., Park, S. J., Shin, H., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118270 · Cited by 8 · see citing works
Delapaz, N. R., Hor, W. K., Gilbert, M., La, A. D., Liang, F., Fan, P., Qi, X., Guo, X., Ying, J., Sakolsky, D. J., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11030178 · Cited by 8 · see citing works
Sundararaj, S., Gazi, A. H., Vaccarino, V., Shah, A. J., Inan, O. T., & Bremner, J. D. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1456662 · Cited by 7 · see citing works
Nickson, D., Singmann, H., Meyer, C., Toro, C. T., & Walasek, L. (2023) · Diagnostic and Prognostic Research · doi:10.1186/s41512-023-00160-2 · Cited by 7 · see citing works
Li, C., Xiao, L., Lin, W., Li, M., Liu, J., Qiu, X., Li, M., Zheng, Y., Xu, C., Wang, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50042-4 · Cited by 6 · see citing works
Davis, L. L., Urganus, A., Gagnon-Sanschagrin, P., Maitland, J., Qu, W., Cloutier, M., Guérin, A., & Aggarwal, J. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2269839 · Cited by 6 · see citing works
“PTSD-specific clinical management of patients with PTSD may help to reduce the overall disease burden and often involves careful assessment of the nature of the trauma and provision of trauma-focused psychotherapy and/or pharmacological treatments [9,23,24].”
BackgroundCase series: Continued remission of PTSD symptoms after discontinuation of prazosin
Richardson, C. S., Yuh, J. Y., Su, J., & Forsberg, M. M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1172754 · Cited by 6 · see citing works
Benzouak, T., Danyluck, C. M., Gunpat, S., Amougou, S. E., Hamoudeh, R. A., Prudencio-Brunello, M. A., Nachabe, J., Edwin, F., Kisely, S. R., & Rao, S. (2025) · BJPsych Open · doi:10.1192/bjo.2025.10057 · Cited by 5 · see citing works
Hassan, A. N., Agabani, Z., Ferkul, S., Minami, O., Foll, B. L., Ahmed, C., & Bormann, J. E. (2024) · Mindfulness · doi:10.1007/s12671-024-02465-9 · Cited by 4 · see citing works
PTSD biomarkers: Neuroendocrine signaling to epigenetic variants
Sbisa, A. M., Graham, K., Lawrence‐Wood, E., McFARLANE, A. C., & Toben, C. G. (2024) · Advances in clinical chemistry · doi:10.1016/bs.acc.2024.06.004 · Cited by 4 · see citing works
Zhao, Y.-F., Huang, C., Zhang, Z., Liu, R.-B., Liu, J.-L., Li, X., Guo, G., & Zhang, C. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07157-9 · Cited by 4 · see citing works
Effects of Intravenous Ketamine on Posttraumatic Stress Disorder ( PTSD ): A Systematic Review
Yin, L., Lu, A., Le, G. H., Dri, C. E., Wong, S., Teopiz, K. M., Xu, H., Ho, R., Rhee, T. G., Lo, H. K. Y., et al. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70053 · Cited by 4 · see citing works
Sultan, W., Madiedo, A., & Moreno‐Sanz, G. (2024) · Medical Cannabis and Cannabinoids · doi:10.1159/000540978 · Cited by 3 · see citing works
(2021) · Wiley eBooks · doi:10.1002/9781119870203.mpg005 · Cited by 3 · see citing works
Алилуев, А. В., Семенова, Л. Ю., Порядин, Г. В., Manukhina, E. B., Dauni, G. F., Goryacheva, A. V., Мальцева, Н. В., Евгеньевич, Ш. С., Karpenko, M. N., Pestereva, N. S., et al. (2021) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2021.03.12-20 · Cited by 2 · see citing works
Treatment of Co-occurring PTSD and Aggression: Current Psychotherapy and Pharmacological Approaches
Krauss, A., McCloskey, M. S., Creech, S. K., & Goodman, M. S. (2023) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-023-00282-w · Cited by 2 · see citing works
Exploring gene-drug interactions for personalized treatment of post-traumatic stress disorder
Skolariki, K., & Vlamos, P. (2024) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2023.1307523 · Cited by 2 · see citing works
Thirayan, V., Kong, V. Y., Uchino, H., & Clarke, D. (2024) · South African Journal of Surgery · doi:10.36303/sajs.00202 · Cited by 2 · see citing works
Timchenko, Y., Lyubinets, O. V., Oliinyk, P., Chaplyk, V. V., & Olіinyk, S. (2022) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2022.3.253119 · Cited by 2 · see citing works
Posttraumatic stress disorder: An overview in new diagnosis and treatment approaches
Pejušković, B. (2024) · Medicinska istrazivanja · doi:10.5937/medi57-44935 · Cited by 1 · see citing works
Balconi, M., Gobbi, E., Pagnoni, I., Campana, E., Sandrini, M., Manenti, R., & Cotelli, M. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08430-1 · Cited by 1 · see citing works
Korol, N. I., Slivka, M. V., & Головко-Камошенкова, О. М. (2020) · Organic Communications · doi:10.25135/acg.oc.88.20.11.1870 · Cited by 1 · see citing works
Micek, A., Jagielski, P., Bolesławska, I., Witkowska, A. M., Waśkiewicz, A., Wajda, Z., Kamińska, A., Cebula, A., & Godos, J. (2024) · Nutrients · doi:10.3390/nu16030445 · Cited by 1 · see citing works
Gable, K. N. (2021) · Pharmacy Today · doi:10.1016/j.ptdy.2021.08.021
Part I: Interactive case: Adverse effects associated with antipsychotic therapy
Gardner, K. N. (2021) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1563
Visuospatial game in PTSD symptoms alleviation: intervention overview and clinical studies results
Czernecka, K. (2023) · Kwartalnik Naukowy Fides et Ratio · doi:10.34766/fetr.v55i3.1213
Cannabidiol, a promising therapy for post-traumatic stress disorder and depression. A mini-review
Jîtcă, G. (2024) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2024-0012
Decoding PTSD and Paving the Way for Healing
Tripathi, R. K. P. (2024) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-2089-1.ch004
Prescribing in Children and Adolescents
(2025) · Wiley eBooks · doi:10.1002/9781119870203.mpg005.pub2
Bondarenko, L. B., Karatsuba, T. A., Voronina, A., Мунько, М. А., Kovalenko, V. M., & Shayakhmetova, G. M. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174143
The toll of the cyclone: mental health impacts of tropical cyclones in coastal communities of India
George, P. R., & Chakrabarti, S. (2025) · BMC Public Health · doi:10.1186/s12889-025-25939-4
Nickson, D., Meyer, C., Walasek, L., & Toro, C. T. (2024) · Figshare · doi:10.6084/m9.figshare.26645698
Torun, H. O., Akdöner, B., Sarıkavak, T., & Kırlı, U. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1715590
Pierce, Z. P., & Nelson, C. (2026) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2026.112207
Methylphenidate-associated improvement in complex functional/ dissociative disorder: A case report
Laatsch, J., Philipsen, A., & Pensel, M. C. (2026) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2026.100338
Jackson, B. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1895931
Retinal layer structure on optical coherence tomography in post-traumatic stress disorder
Patel, S. D., Karthik, N., Justin, G. A., Haystead, A., Chiu, S. J., Stinnett, S. S., Johnson, K. G., Grewal, D. S., & Fekrat, S. (2026) · PLoS ONE · doi:10.1371/journal.pone.0360471
- Authors
- Ehret, M.
- Corresponding author
- Ehret, Megan
- ORCID
- Ehret, Megan
- Venue
- Mental Health Clinician
- Published
- 2019-11-01
- Volume
- 9
- Issue
- 6
- Pages
- 373-382
- ISSN
- 2168-9709 (ISSN-L)
- PMC
- PMC6881110
- OpenAlex
- W2990240408
- Cited by
- 53
- References
- 58
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 14 · 2023: 8 · 2022: 7 · 2021: 8 · 2020: 3
- FWCI
- 5.26
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Mental Health Clinician (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Posttraumatic Stress Disorder Research
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
- Keywords
- post-traumatic stress disorder, pharmacotherapy, selective serotonin reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, psychotropic drugs, treatment guidelines, drug selection, comorbidities, symptomatology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
